StonvexLoading…
StonvexStonvexStonvexCore line items from RNGE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $915.38K | $3.71M | $569.95K | $1.11M |
Operating Income | $-1.80M | $-1.74M | $-719.58K | $-318.87K |
Net Income | $-1.83M | $19.17M | $-813.04K | $-1.03M |
EPS (Diluted) | $-0.02 | $0.18 | $-0.01 | $-0.01 |
Total Assets | $121.97M | $123.24M | $57.56M | $58.22M |
Total Liabilities | $85.86M | $85.45M | $51.73M | $52.31M |
Cash & Equivalents | $1.28M | $2.11M | $285.39K | $48.31K |
Free Cash Flow OCF − CapEx | Not available | Not available | $-80.89K | $14.01K |
Shares Outstanding | 113.32M | 112.28M | 112.28M | 108.62M |